What is the END Fund's mission?
In their own words, the END Fund focuses on "delivering neglected tropical disease (NTD) treatments to those in need by growing and engaging a community of activist-philanthropists, managing high-impact strategic investments, and working in collaboration with government, NGO, pharmaceutical, and academic partners."
What does the END Fund do?
- The END Fund examines the global neglected tropical disease (NTD) landscape and directs funding to the programs it expects to achieve the highest impact.
- It raises funding for NTD programs through active engagement with donors and philanthropic foundations.
- The END Fund's deworming programs treat schistosomiasis and soil-transmitted helminthiasis.
- It monitors its impact, requesting grantees' plans, budgets, and treatment schedules, and in some cases provides technical assistance.
Why do we recommend the END Fund?
- Deworming is considered a highly cost-effective intervention that remains underfunded globally. * The END Fund is a highly transparent organisation and shares significant and detailed information publicly.
- GiveWell has identified the END Fund's deworming programs as a "top-rated" giving opportunity.
To learn more about the END Fund, we recommend reading more on GiveWell's detailed review.
- The END Fund reports that, since its founding in 2012, it has “treated more than 140 million people with 330 million treatments,” trained more than 900,000 health workers, and provided more than 10,000 surgeries.
- Its work is primarily focused on treating children in Africa, where the burden of disease caused by worm infections is the highest.
- We recommend the End Fund specifically for its deworming program, which was evaluated by GiveWell.